Smartphone-Based Real-Time Assessment of Daytime Insomnia Symptoms With Suvorexant

What is the effect of insomnia suvorexant pharmacotherapy on daytime insomnia symptoms as assessed via smartphone ecological momentary assessment (EMA)?In this randomized clinical trial that included 40 older adults with insomnia, traditional outcomes assessments detected differences between suvorexant and placebo groups in daytime insomnia symptoms; however, EMA was sensitive to detect effects of insomnia pharmacotherapy at various times of day.These findings suggest that EMA warrants further refinement in sleep and psychiatric research and clinical care.

Corresponding Author: Emerson M. Wickwire, PhD, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Maryland School of Medicine, 100 N Greene St, 2nd Floor, Baltimore, MD 21201 (ewickwire@som.umaryland.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.